Michael Honigberg, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Comanche Biopharma(MODEST) RESEARCH/RESEARCH GRANTS: Genentech, Inc(NONE) OTHER FINANCIAL BENEFIT: Miga Health(MODEST), Novartis Corporation(NONE)

View Full Disclosure